Curve Biosciences: $40 Million Raised To Advance Whole-Body Intelligence Platform for Chronic Disease Monitoring
By Amit Chowdhry ● Oct 30, 2025
Curve Biosciences, a biotechnology company pioneering Whole-Body Intelligence for proactive and personalized chronic disease care, has raised $40 million in new funding led by Luma Group, with participation from First Spark Ventures, Techas Capital, Micah Spear, Civilization Ventures, LifeX Ventures, Incite, Mintaka VC, NZVC, and others.